Prospective Evaluation of the Effects of Anxiety Sensitivity and State Anxiety in Predicting Acute Nicotine Withdrawal Symptoms During Smoking Cessation

被引:54
|
作者
Johnson, Kirsten A. [1 ]
Stewart, Sherry [2 ,3 ,4 ]
Rosenfield, David [5 ]
Steeves, Dan [6 ]
Zvolensky, Michael J. [1 ]
机构
[1] Univ Vermont, Dept Psychol, Burlington, VT 05405 USA
[2] Dalhousie Univ, Dept Psychiat, Halifax, NS, Canada
[3] Dalhousie Univ, Dept Psychol, Halifax, NS, Canada
[4] Dalhousie Univ, Dept Community Hlth & Epidemiol, Halifax, NS, Canada
[5] So Methodist Univ, Dept Psychol, Dallas, TX 75275 USA
[6] Capital Dist Hlth Author, Nova Scotia Dept Hlth Promot & Protect, Dartmouth, NS, Canada
关键词
smoking; state anxiety; anxiety sensitivity; nicotine withdrawal; smoking cessation; FAGERSTROM TOLERANCE QUESTIONNAIRE; PANIC-ATTACKS; DAILY SMOKERS; OUTCOME EXPECTANCIES; TOBACCO WITHDRAWAL; DISTRESS TOLERANCE; BODILY SENSATIONS; NEGATIVE AFFECT; DRUG-USE; DEPENDENCE;
D O I
10.1037/a0024133
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
The current investigation explored the main and interactive effects of anxiety sensitivity (AS) and state anxiety in predicting acute nicotine withdrawal symptoms experienced during the initial 14 days of smoking cessation. Participants included 123 adult daily smokers (84 women; M-age = 45.93 years, SD = 10.34) undergoing psychosocial pharmacological cessation treatment. Results indicated that after controlling for the effects of participant sex and nicotine dependence, state anxiety but not AS significantly predicted initial levels of nicotine withdrawal symptoms. Results also demonstrated that both state anxiety and AS were significantly related to the change in nicotine withdrawal symptoms over time. Finally, our results revealed a significant interaction between AS and state anxiety. Specifically, higher levels of AS were associated with a stronger relation between state anxiety and nicotine withdrawal symptoms experienced during the cessation attempt. Results suggest that among high AS persons, state anxiety may be more relevant, compared to those low in AS, in regard to experiencing withdrawal symptoms as more intense during the early phases of quitting.
引用
收藏
页码:289 / 297
页数:9
相关论文
共 50 条
  • [41] Effects of Varenicline and Bupropion Sustained-Release Use Plus Intensive Smoking Cessation Counseling on Prolonged Abstinence From Smoking and on Depression, Negative Affect, and Other Symptoms of Nicotine Withdrawal
    Cinciripini, Paul M.
    Robinson, Jason D.
    Karam-Hage, Maher
    Minnix, Jennifer A.
    Lam, Cho
    Versace, Francesco
    Brown, Victoria L.
    Engelmann, Jeffrey M.
    Wetter, David W.
    JAMA PSYCHIATRY, 2013, 70 (05) : 522 - 533
  • [42] Selective CRF2 receptor agonists ameliorate the anxiety- and depression-like state developed during chronic nicotine treatment and consequent acute withdrawal in mice
    Bagosi, Zsolt
    Palotai, Miklos
    Simon, Balks
    Bokor, Peter
    Buzas, Andras
    Balango, Beata
    Pinter, David
    Jaszberenyi, Miklos
    Csabafi, Krisztina
    Szabo, Gyula
    BRAIN RESEARCH, 2016, 1652 : 21 - 29
  • [43] Anxiety Sensitivity and Pre-Cessation Smoking Processes: Testing the Independent and Combined Mediating Effects of Negative Affect-Reduction Expectancies and Motives
    Farris, Samantha G.
    Leventhal, Adam M.
    Schmidt, Norman B.
    Zvolensky, Michael J.
    JOURNAL OF STUDIES ON ALCOHOL AND DRUGS, 2015, 76 (02) : 317 - 325
  • [44] The effects of reduced nicotine content cigarettes on biomarkers of nicotine and toxicant exposure, smoking behavior and psychiatric symptoms in smokers with mood or anxiety disorders: A double-blind randomized trial
    Foulds, Jonathan
    Veldheer, Susan
    Pachas, Gladys
    Hrabovsky, Shari
    Hameed, Ahmad
    Allen, Sophia, I
    Cather, Corinne
    Azzouz, Nour
    Yingst, Jessica
    Hammett, Erin
    Modesto, Jennifer
    Krebs, Nicolle M.
    Lester, Courtney
    Trushin, Neil
    Reinhart, Lisa
    Wasserman, Emily
    Zhu, Junjia
    Liao, Jason
    Muscat, Joshua E.
    Richie, John P., Jr.
    Evins, A. Eden
    PLOS ONE, 2022, 17 (11):
  • [45] Acute effects of outdoor and indoor walking on cigarette cravings, withdrawal symptoms and affective response during temporary smoking abstinence
    Stefanie E. Schöttl
    Kathrin Insam
    Anika Frühauf
    Prisca Kopp-Wilfling
    Bernhard Holzner
    Martin Kopp
    Psychopharmacology, 2024, 241 : 739 - 752
  • [46] Acute effects of outdoor and indoor walking on cigarette cravings, withdrawal symptoms and affective response during temporary smoking abstinence
    Schoettl, Stefanie E.
    Insam, Kathrin
    Fruehauf, Anika
    Kopp-Wilfling, Prisca
    Holzner, Bernhard
    Kopp, Martin
    PSYCHOPHARMACOLOGY, 2024, 241 (04) : 739 - 752
  • [47] Anxiety sensitivity explains associations between anxious arousal symptoms and smoking abstinence expectancies, perceived barriers to cessation, and problems experienced during past quit attempts among low-income smokers
    Zvolensky, Michael J.
    Paulus, Daniel J.
    Langdon, Kirsten J.
    Robles, Zuzuky
    Garey, Lorra
    Norton, Peter J.
    Businelle, Michael S.
    JOURNAL OF ANXIETY DISORDERS, 2017, 48 : 70 - 77
  • [48] Effects of n-3 polyunsaturated fatty acids on depressive symptoms, anxiety and emotional state in patients with acute myocardial infarction
    Maciej Haberka
    Katarzyna Mizia-Stec
    Magdalena Mizia
    Klaudia Gieszczyk
    Artur Chmiel
    Katarzyna Sitnik-Warchulska
    Zbigniew Gąsior
    Pharmacological Reports, 2013, 65 : 59 - 68
  • [49] Effects of n-3 polyunsaturated fatty acids on depressive symptoms, anxiety and emotional state in patients with acute myocardial infarction
    Haberka, Maciej
    Mizia-Stec, Katarzyna
    Mizia, Magdalena
    Gieszczyk, Klaudia
    Chmiel, Artur
    Sitnik-Warchulska, Katarzyna
    Gasior, Zbigniew
    PHARMACOLOGICAL REPORTS, 2013, 65 (01) : 59 - 68
  • [50] Anxiety Sensitivity and Panic Reactivity to Bodily Sensations: Relation to Quit-Day (Acute) Nicotine Withdrawal Symptom Severity Among Daily Smokers Making a Self-Guided Quit Attempt
    Marshall, Erin C.
    Johnson, Kirsten
    Bergman, Jenna
    Gibson, Laura E.
    Zvolensky, Michael J.
    EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 2009, 17 (05) : 356 - 364